Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
Sanofi's Sarclisa is the first cancer drug to receive FDA approval for delivery via an on-body injector.
Evidence dossier
Intelligence passport
Measured timeline
- Detected The first matching coverage entered the Archynetys cluster.
- Latest coverage observed Most recent article currently attached to this story cluster.
- Peak measured velocity The recorded velocity reached 6.
- Evidence threshold reached The story had enough independent coverage for an explanatory brief.
- Outcome review added Archynetys revisited the signal after coverage cooled.
Source diversity sample: Oncodaily · Pharmaceutical Executive · AJMC · Yahoo Finance · TradingView · PharmTech.com · Reuters · Fierce Pharma.
How this dossier is built: methodology · AI policy · corrections.
📍 Where it landed
The FDA approved Sanofi's Sarclisa Escena, an on-body injector for the treatment of multiple myeloma. This marked the first cancer drug delivered by a wearable injector.
Epilogue added 42d ago, after coverage quieted.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
FDA has approved Sarclisa Escena, a subcutaneous form of isatuximab used to treat multiple myeloma. This approval marks the first time a cancer drug has been authorized for delivery using a wearable, on-body injector device.
Coverage from Reuters, Fierce Pharma, and Pharmaceutical Executive emphasizes the novelty of the delivery method. AJMC notes that the approval increases competition among anti-CD38 therapies for multiple myeloma.
Other reports, such as those from Yahoo Finance, mention a concurrent antitrust probe by the EU. Future developments include the implementation of this subcutaneous injection for multiple myeloma indications and the resulting impact on the competitive landscape of the market.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 42d ago.
The reporting (9)
- Galina Bernstein: FDA Approves Subcutaneous Isatuximab for Multiple Myeloma Oncodaily · 46d ago
- FDA Approves Subcutaneous Isatuximab for Multiple Myeloma Oncodaily · 46d ago
- FDA Approves Subcutaneous Sarclisa Escena Pharmaceutical Executive · 46d ago
- FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma AJMC · 46d ago
- Sanofi (ENXTPA:SAN) Wins FDA Nod For Sarclisa Escena As EU Opens Antitrust Probe Yahoo Finance · 46d ago
- FDA Approves Isatuximab-Irfc For Subcutaneous Injection For Multiple Myeloma Indications On July 9 TradingView · 46d ago
- The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma PharmTech.com · 46d ago
- US FDA approves Sanofi's wearable injector form of blood cancer drug Reuters · 46d ago
- Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector Fierce Pharma · 46d ago
Quick answers
What drug was approved by the FDA?
The FDA approved Sarclisa Escena, also referred to as subcutaneous isatuximab.
What is unique about this approval?
It is the first cancer drug delivered by an on-body injector.
What condition is the drug used to treat?
The drug is used for multiple myeloma.
Topics
Related trends
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly
The FDA has granted clearance for the first blood-based biomarker test for Alzheimer's disease, developed through a partnership between Roche and Eli Lilly.
Bad Food
The US food industry is under scrutiny as a cyclospora outbreak raises questions about safety and corruption.
Philip Morris gets FDA nod for 11 new nicotine pouches
The FDA's approval of 11 new nicotine pouches by Philip Morris is stirring market anticipation and regulatory scrutiny.
Blueberries, guacamole, granola. See list of recent food recalls
A wave of food recalls has swept the U.S. this summer, affecting popular items like blueberries, guacamole and granola.
Taylor Farms lettuce may have reached 7 more states, D.C. and Puerto Rico
Expanded distribution of potentially contaminated Taylor Farms lettuce increases exposure risks across 7 states, Washington D.C., and Puerto Rico.
Why does it seem like food recalls are out of control this year?
Food recalls have surged in 2026, affecting a wide range of products and raising questions about safety and regulation.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.